by Omar Figueroa July 14, 2021 United States Senators Cory Booker, Ron Wyden, and Chuck Schumer have released their long-awaited federal legalization bill, the Cannabis Administration & Opportunity Act. The text of the discussion draft can be found here, and a summary can be found here. The Senate’s 163-page Cannabis […]
Read More
By Lauren Mendelsohn June 29, 2021 On June 28, 2021, the United States Supreme Court declined to take up the issue of tax treatment of cannabis businesses in Standing Akimbo, LLC, et al. v. United States, 594 U.S. __ (2021), which had come before the Supreme Court on a petition […]
Read More
By Transactional Attorney Daniel Dellafosse June 18, 2021 On May 28, 2021, the “Marijuana Opportunity Reinvestment and Expungement Act of 2021” (the “MORE Act of 2021”) was introduced in the United States Congress. Senior Associate Attorney Lauren Mendelsohn wrote a brief blog post describing a few key details […]
Read More
by Lauren Mendelsohn May 28, 2021 Today, Judiciary Committee Chairman Jerrold Nadler (D-NY) introduced the “Marijuana Opportunity Reinvestment and Expungement Act of 2021” (the “MORE Act of 2021”) in the United States Congress. The MORE Act of 2021 is a landmark bill, as it would legalize cannabis nationwide. The MORE […]
Read More
By Lauren Mendelsohn May 14, 2021 The recent settlement of a prominent cannabis company for making health-related claims about CBD products should serve as a reminder to cannabis and non-cannabis companies alike that the United States Food and Drug Administration (FDA) has not approved CBD or THC as a […]
Read More
By Lauren Mendelsohn, Esq. March 31, 2021 The Law Offices of Omar Figueroa is honored to announce success in obtaining federal registration from the United States Patent and Trademark Office (USPTO) for the “EQUITY TRADE” certification mark (U.S. Registration No. 6310040), which is used to designate products that are made […]
Read More
By Lauren Mendelsohn January 19, 2021 On Friday, January 15, 2021 the United States Department of Agriculture (USDA) issued its much-anticipated final rule on domestic hemp production. The final rule incorporates some key changes that industry stakeholders have been pushing for since the interim final rule was published in 2019. […]
Read More
January 11, 2021 by Omar Figueroa 3,4-Methylenedioxymethamphetamine (MDMA), or “Ecstasy” as it is colloquially known, has been the focus of intense research in recent years. For example, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced that the Food and Drug Administration has designated MDMA-assisted therapy for post-traumatic stress disorder (PTSD) […]
Read More
by Omar Figueroa December 6, 2020 On Thursday, December 3, 2020, the United States House of Representatives passed H.R. 3884, known as the Marijuana Opportunity Reinvestment and Expungement Act of 2020 (MORE Act.) This historic bill aimed to decriminalize and deschedule cannabis, to provide for reinvestment in persons adversely […]
Read More
By Lauren Mendelsohn September 27, 2020 Last week, the California Department of Food and Agriculture (CDFA) notified the public that they have submitted the Golden State’s proposed regulatory plan for hemp production to the United States Department of Agriculture (USDA). California’s proposed hemp production plan, which consists of existing […]
Read More